Bulletin
Investor Alert

New York Markets Open in:

Immunovant Inc.

NAS: IMVT

GO
/marketstate/country/us

Before the Bell

/zigman2/quotes/212869794/composite

$

12.82

Change

-0.40 -3.03%

Volume

Volume 1

Nov 28, 2022, 6:45 a.m.

Quotes are delayed by 20 min

/zigman2/quotes/212869794/composite

Previous close

$ 13.22

$ 13.22

Change

-0.08 -0.60%

Day low

Day high

$13.13

$13.40

Open
Open: 13.38

52 week low

52 week high

$3.15

$13.48

Open

Market cap

$1.71B

Average volume

1.36M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.52

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/imvt

MarketWatch News on IMVT

  1. Immunovant downgraded to neutral from buy at UBS

    7:55 a.m. Sept. 26, 2022

    - Tomi Kilgore

  2. Immunovant stock price target cut to $5 from $7 at UBS

    7:56 a.m. Sept. 26, 2022

    - Tomi Kilgore

  3. Immunovant stock price target cut to $7 from $33 at UBS

    9:19 a.m. May 20, 2022

    - Tomi Kilgore

  4. Biogen's FDA Win Marks a Mini-Rally in Biotech Stocks

    9:20 a.m. June 16, 2021

    - Barron's Online

  5. Argenx Is a Biotech Stock With Big Potential

    2:42 p.m. June 15, 2021

    - Barron's Online

  6. Will Biotech Stocks' Slide Become a Rout? June Holds the Key.

    1:46 p.m. May 14, 2021

    - Barron's Online

  7. Immunovant started at buy with $46 stock price target at Stifel Nicolaus

    7:24 a.m. Oct. 8, 2020

    - Tomi Kilgore

  8. Immunovant price target raised to $52 from $36 at Truist Securities, stock rated buy

    6:21 a.m. Aug. 26, 2020

    - Tonya Garcia

  9. Immunovant initiated at outperform with $35 price target at Raymond James

    7:15 a.m. Aug. 25, 2020

    - Tonya Garcia

  10. Immunovant stock price target raised to $34 from $26 at SVB Leerink

    6:21 a.m. Aug. 20, 2020

    - Tomi Kilgore

  11. Immunovant stock price target raised to $37 from $27 at Instinet

    7:27 a.m. May 29, 2020

    - Tomi Kilgore

  12. Immunovant started at buy with $24 stock price target at SunTrust RH

    7:27 a.m. Jan. 10, 2020

    - Tomi Kilgore

/news/nonmarketwatch/company/us/imvt

Other News on IMVT

  1. Are Medical Stocks Lagging BioVie (BIVI) This Year?

    9:40 a.m. Nov. 25, 2022

    - Zacks.com

  2. Immunovant GAAP EPS of -$0.41

    6:31 a.m. Nov. 4, 2022

    - Seeking Alpha

  3. 10-Q: IMMUNOVANT, INC.

    6:27 a.m. Nov. 4, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. Immunovant (IMVT) Set to Develop Lead Candidate Batoclimab

    12:56 p.m. Oct. 20, 2022

    - Zacks.com

  5. Immunovant stock down on raising $75M though equity capital

    7:48 a.m. Oct. 4, 2022

    - Seeking Alpha

  6. MOTS, PPSI and IMVT among mid-day movers

    11:57 a.m. Sept. 29, 2022

    - Seeking Alpha

  7. Immunovant, Inc. (IMVT) Upgraded to Buy: Here's Why

    11:00 a.m. Sept. 2, 2022

    - Zacks.com

  8. Loading more headlines...
/news/pressrelease/company/us/imvt

Press Releases on IMVT

  1. Friday 9/30 Insider Buying Report: ISSC, IMVT

    12:33 p.m. Sept. 30, 2022

    - MarketNewsVideo.com

  2. Immunovant Announces IMVT-1402, a Next Generation Anti-FcRn

    9:45 a.m. Sept. 28, 2022

    - GlobeNewswire

  3. Immunovant to Present at Roivant Investor Day on September 28th

    7:00 a.m. Sept. 21, 2022

    - GlobeNewswire

  4. Immunovant to Host Virtual R&D Day on March 30, 2022

    6:00 a.m. March 28, 2022

    - GlobeNewswire

  5. Loading more headlines...

Rates »

Link to MarketWatch's Slice.